Stories tagged 'Transplant and Immunotherapy'

Celebrating faculty and staff achievements

Aug. 17, 2017

Dr. Filippo Milano and colleagues in the Cord Blood Program at Fred Hutch have received funding from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation to support a clinical trial to improve the use of umbilical cord blood as a treatment for leukemia ... and more good news at Fred Hutch.

Celebrating faculty and staff achievements

Aug. 3, 2017

Fred Hutch's Dr. Slobodan Beronja and colleagues at Yale University have published new findings in Nature that show healthy skin cells can fight off the cancerous tendencies of nearby cells that harbor cancer-causing mutations.

High response rates to experimental immunotherapy in patients with treatment-resistant chronic lymphocytic leukemia

July 17, 2017
| By Susan Keown / Fred Hutch News Service

Most patients with recurrent chronic lymphocytic leukemia who were enrolled in a small, early- phase trial saw their advanced tumors shrink or even disappear after an infusion of genetically engineered immune cells. Dr. Cameron Turtle, one of the study’s leaders, presented the results on Saturday at the 2016 annual meeting of the American Society of Hematology in San Diego.